Topical henna for capecitabine induced hand-foot syndrome

Investigational New Drugs

Volumn 26, Issue 2, 2008, Pages 189-192

  Yucel, Idris ^a   Guzin, Gonullu ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Capecitabine; Hand foot; Henna

Indexed keywords

CAPECITABINE; DOCETAXEL; HENNA;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HAND FOOT SYNDROME; HUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MIDDLE AGED; NAPHTHOQUINONES; NEOPLASMS; PARESTHESIA; SEVERITY OF ILLNESS INDEX; SYNDROME; TREATMENT OUTCOME;

EID: 40549112710     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-007-9082-3     Document Type: Article

References (15)

1. Shimma N, Umeda I, Arasaki M, Murasaki C, Masubuchi K, Kohchi Y (2000) The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine. Bioorg Med Chem 8:1697-1706
2. Marsé H, Van Cutsem E, Grothey A, Valverde S (2004) Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8:16-30
3. Comandone A, Bretti S, La Grotta G, Manzoni S, Bonardi G, Berardo R, Bumma C (1993) Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment. Anticancer Res 13:1781-1783
4. Gordon KB, Tajuddin A, Guitart J, Kuzel TM, Eramo LR, VonRoenn J (1995) Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer 75:2169-2173
5. Lopez AM, Wallace L, Dorr RT, Koff M, Hersh EM, Alberts DS (1999) Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol 44:303-306
6. Komamura H, Higashiyama M, Hashimoto K, Takeda K, Kimura H, Tani Y (1995) Three cases of chemotherapy-induced acral erythema. J Dermatol 22:116-121
7. Mortimer JE, Lauman MK, Tan B (2003) Pyridoxine treatment and prevention of hand-foot syndrome in patients receiving capecitabine. J Oncol Pharm Pract 9:161-166
8. Kandil HH, al-Ghanem MM, Sarwat MA, al-Thallab FS (1996) Henna (Lawsonia inermis Linn.) inducing haemolysis among G6PD-deficient newborns. A new clinical observation. Ann Trop Paediatr 16:287-291
9. Mikhaeil BR, Badria FA, Maatooq GT, Amer MM (2004) Antioxidant and immunomodulatory constituents of henna leaves. Z Naturforsch [C] 59:468-476
10. Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17:485-493
11. Lassere Y, Hoff P (2004) Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). Eur J Oncol Nurs 8:31-40
12. Mrozek-Orlowski ME, Frye DK, Sanborn Hm (1999) Capecitabine: nursing implications of a new oral chemotherapeutic agent. Oncol Nursing Forum 26:753-762
13. Gerbrecht BM (2003) Current Canadian experience with capecitabine. Cancer Nursing 26:161-167
14. Fabian CJ, Molina R, Slavik M, Dahlberg S, Girl S, Stephens R (1990) Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 8:57-63
15. Ali BH, Bashir AK, Tanira MO (1995) Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats. Pharmacology 51:356-363